ClinicalTrials.Veeva

Menu

The Effectiveness of Biofeedback for Individuals With Long-term Post-concussive Symptoms

W

Western University, Canada

Status

Completed

Conditions

Post-Concussion Syndrome

Treatments

Device: Heart Rate Variability Biofeedback
Device: Neurofeedback

Study type

Interventional

Funder types

Other

Identifiers

NCT03338036
Western University REB 109760

Details and patient eligibility

About

Most concussions resolve within 7-10 days, but approximately 40% of individuals do not fully recover and suffer from persistent post-concussive symptoms. This 8-week intervention study will evaluate the efficacy of heart rate variability (HRV) biofeedback and neurofeedback on reducing the number and severity of concussion symptoms.

Full description

40% of minor head injuries are diagnosed with post-concussion syndrome 3 months after injury (Ingebrigtsen, Waterloo, Marup-Jensen, Attner, & Romner, 1998). These individuals have persistent symptoms after completing conventional rehabilitation programs. Persistent post-concussion symptoms not only decrease quality of life (Ingebrigtsen et al, 1998), but also impair cognitive and motor performance and increase the likelihood of impaired driving performance (Preece, Horswill, & Geffen, 2010) and motor vehicle accidents (Bivona et al, 2012). While case reports indicate that biofeedback can reduce the number and severity of post-concussive symptoms (Lagos, Thompson, & Vaschillo, 2013; Thompson, Thompson, Reid-Chung, & Thompson, 2013), no studies have systematically evaluated these biofeedback treatment programs.

HRV biofeedback works by displaying beat-to-beat heart rate data to the participant, and through operant conditioning with breathing techniques, the participant learns to control their HRV (Lehrer & Gevirtz, 2014). This results in an increase in parasympathetic (PNS) activity and decrease in sympathetic (SNS) activity, which leads to reduced anxiety, and increased focus and concentration (Lagos, Bottiglieri, Vaschillo, & Vaschillo, 2012). Neurofeedback works in a similar fashion, except it monitors brain wave power, frequency, and connectivity using quantitative electroencephalogram (EEG). Brain functioning is displayed while playing an electronic game, and the participant learns through operant conditioning to increase the amplitude of desired EEG frequencies, such as low beta waves that are associated with active problem solving, usually while simultaneously decreasing the amplitudes of undesired EEG frequencies (Conder & Conder, 2014).

This will be an eight-week intervention where participants suffering from long-term post-concussion symptoms will be recruited using email from the cohort of individuals that have been discharged after completing a concussion rehabilitation protocol (BrainEx90) at Parkwood Institute in London, Ontario. Non-concussed control participants will be recruited using posters. Participants will complete pre, mid, and post-intervention driving simulation tasks, electrocardiogram and HRV measures, and subjective questionnaires. These will be utilized to evaluate the effectiveness of HRV biofeedback and neurofeedback in this difficult to treat population.

Enrollment

31 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Participants in HRV and the HRV/Neurofeedback intervention arms, and the post-concussion control arm:

  1. Previously suffered a clinically diagnosed concussion
  2. Participated in, completed, and have been discharged from the BrainEx90 outpatient concussion rehabilitation program at Parkwood Institute
  3. Continued post-concussive symptoms
  4. 18 years of age or older
  5. Access to transportation
  6. Capable of utilizing hand-held technology (ie. cell phone, tablet, etc.)
  7. Holds a valid Driver's License
  8. English speaking

Participants in the non-concussed control arm:

  1. 18 years of age or older
  2. Holds a valid driver's license
  3. English speaking
  4. Has not suffered a concussion in the last two years

Exclusion criteria

All participants:

  1. Any heart disease, pacemaker, abnormal heartbeat patterns, coronary artery disease, or bypass surgery
  2. Any mental health disorder that would interfere with participation in the study
  3. Under 18 years of age
  4. Unable to provide written informed consent or complete questionnaires due to language or cognitive difficulties
  5. Inability to operate a motor vehicle
  6. Inability to look at a digital screen for 30 minutes

Participants in the non-concussed control arm:

  1. Suffered a concussion in the last two years

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

31 participants in 3 patient groups

Heart Rate Variability/Neurofeedback
Experimental group
Description:
Participants in this arm of the study will receive HRV biofeedback and neurofeedback. HRV biofeedback will occur twice daily, using an android device and application. Additionally, three times per week they will have one-hour long neurofeedback sessions.
Treatment:
Device: Heart Rate Variability Biofeedback
Device: Neurofeedback
Post-Concussed Control Group
No Intervention group
Description:
Age-matched, previously concussed individuals that have completed the same concussion rehabilitation program (Brain Ex 90) will be recruited for this arm.
Non-Concussed Control Group
No Intervention group
Description:
Age-matched individuals who have not been diagnosed with a concussion in the previous two years

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems